| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |